Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Safety Run-In Phase (Part 1): • To evaluate the safety and tolerability of INCB039110 in combination with docetaxel and select their doses for further evaluation. Randomized Phase (Part 2): • To evaluate and compare the OS of subjects with previously treated advanced or metastatic NSCLC when treated with INCB039110 in combination with docetaxel versus docetaxel alone.
Critère d'inclusion
- Male or female, 18 years or older with histologically or cytologically confirmed diagnosis of NSCLC that is Stage IIIb, IV, or recurrent